Human clinical studies have also examined CD36 polymorphisms associated with enhanced atherosclerotic cardiovascular diseases [38,39], type II diabetes [9], oral fat perception, fat preference and obesity in African-Americans [40] and protection from malaria [41,42]. Here, CD36 is linked to obesity due to melanocortin 4 receptor deficiency.